f PAMAM Dendrimers: Revolutionizing the Targeted Cancer Therapy

References

1. MoazamiyanfarR RezaeiS AliAshrafzadeh H, et al. Nobiletin in cancer therapy; mechanisms and therapy perspectives.Curr. Pharm. Des.202329221713172810.2174/138161282966623042611542437185325
   [Google Scholar]
2. AlmontasserA. Al-MuftiS.M. AryaR.K. Application of nanofillers in drug delivery industry. Handbook of Nanofillers.Berlin, HeidelbergSpringer2023135
   [Google Scholar]
3. Pérez-FerreiroM. M Abelairas A, Criado A, Gómez IJ, Mosquera J. Dendrimers: Exploring their wide structural variety and applications.Polymers (Basel)20231522436910.3390/polym1522436938006093
   [Google Scholar]
4. YasirA.T. BenamorA. HawariA.H. MahmoudiE. Poly (amido amine) dendrimer based membranes for wastewater treatment – A critical review.Chem. Eng. Sci.202327311866510.1016/j.ces.2023.118665
   [Google Scholar]
5. ArkasM. VardavouliasM. KythreotiG. GiannakoudakisD.A. Dendritic polymers in tissue engineering: Contributions of PAMAM, PPI PEG and PEI to injury restoration and bioactive scaffold evolution.Pharmaceutics202315252410.3390/pharmaceutics1502052436839847
   [Google Scholar]
6. CruzA. BarbosaJ. AntunesP. BonifácioV.D.B. PintoS.N. A glimpse into dendrimers integration in cancer imaging and theranostics.Int. J. Mol. Sci.2023246543010.3390/ijms2406543036982503
   [Google Scholar]
7. HsuC.Y. RajhiA.A. AliE. Acetyl-terminated PAMAM dendrimers for pH-sensitive delivery of irinotecan and fluorouracil: A molecular dynamics simulation study.Chem. Phys. Lett.202383214087610.1016/j.cplett.2023.140876
   [Google Scholar]
8. Rodríguez-AcostaG.L. Hernández-MontalbánC. Vega-RazoM.F.S. Castillo-RodríguezI.O. Martínez-GarcíaM. Polymer-dendrimer hybrids as carriers of anticancer agents.Curr. Drug Targets202223437339210.2174/138945012266621090612180334488581
   [Google Scholar]
9. ShuklaA. MaitiP. Nanomedicine and versatile therapies for cancer treatment.MedComm202233e16310.1002/mco2.16335992969
   [Google Scholar]
10. Di FilippoL.D. de PaulaM.C. DuarteJ.L. de PaulaG.A. FrigieriI. ChorilliM. Nanocarrier functionalization strategies for targeted drug delivery in skin cancer therapy: Current progress and upcoming challenges.Expert Opin. Drug Deliv.202320683184910.1080/17425247.2023.222102637259517
    [Google Scholar]
11. ShahP. ShendeP. Biomacromolecule-functionalized nanoparticle-based conjugates for potentiation of anticancer therapy.Curr. Cancer Drug Targets2022221314810.2174/156800962166621120610294234872476
    [Google Scholar]
12. RaiD.B. MedicherlaK. PoojaD. KulhariH. Dendrimer-mediated delivery of anticancer drugs for colon cancer treatment.Pharmaceutics202315380110.3390/pharmaceutics1503080136986662
    [Google Scholar]
13. FakhariS. JamzadM. NouriA. Arab-SalmanabadiS. FalakiF. A novel polyamidoamine dendrimer based nano-carrier for oral delivery of imatinib.J. Polym. Res.2022291252310.1007/s10965‑022‑03359‑x
    [Google Scholar]
14. Barzegar BehroozA. NabavizadehF. AdibanJ. Smart bomb AS 1411 aptamer‐functionalized/PAMAM dendrimer nanocarriers for targeted drug delivery in the treatment of gastric cancer.Clin. Exp. Pharmacol. Physiol.2017441415110.1111/1440‑1681.1267027626786
    [Google Scholar]
15. MaP. YuH. ZhangX. Increased active tumor targeting by an αvβ3-targeting and cell-penetrating bifunctional peptide-mediated dendrimer-based conjugate.Pharm. Res.201734112113510.1007/s11095‑016‑2045‑727848167
    [Google Scholar]
16. MishraV. KesharwaniP. Dendrimer technologies for brain tumor.Drug Discov. Today201621576677810.1016/j.drudis.2016.02.00626891979
    [Google Scholar]
17. YadavD. SemwalB.C. DewanganH.K. Grafting, characterization and enhancement of therapeutic activity of berberine loaded PEGylated PAMAM dendrimer for cancerous cell.J. Biomater. Sci. Polym. Ed.20233481053106610.1080/09205063.2022.215578236469754
    [Google Scholar]
18. WangJ. LiB. QiuL. QiaoX. YangH. Dendrimer-based drug delivery systems: History, challenges, and latest developments.J. Biol. Eng.20221611810.1186/s13036‑022‑00298‑535879774
    [Google Scholar]